Onconomics Plus RGCC
Personalized insights for effective cancer treatments.
SPECIMEN TYPE: BLOOD
TURNAROUND TIME: 17 DAYS
At Vital Positive, we believe every person is unique, requiring personalized treatment plans.
By connecting you with cutting-edge science and individualized medical options, we empower you to take a proactive approach in your fight against cancer.
Personalized Insights for Effective Cancer Treatments
Onconomics Plus RGCC is specifically designed for individuals who have already been diagnosed with cancer, offering tailored treatment insights based on your unique cancer profile.
​
It is a cutting-edge medical test that revolutionizes the landscape of cancer treatment. It stands at the forefront of precision medicine, providing invaluable information into the effect of anti-cancer drugs, targeted therapies, and natural treatments on cancer cells within each individual patient's body.
The process is both simple and profound. Expert scientists meticulously analyze a small blood or tissue sample, diving deep into how cancer cells respond to different therapies. Analyzing these responses, Onconomics Plus RGCC identifies personalized methods to fight cancer that are tailored to each patient.
​
The results derived from these extensive tests form a precise roadmap of the most suitable and successful treatment options available. Armed with this crucial knowledge, Doctors gain a deeper understanding of the patient's cancer and can map out a treatment strategy that optimizes the chances of successful outcomes.
Gone are the days of generic treatment approaches, where patients were treated as mere statistics. Onconomics Plus RGCC empowers medical practitioners with a wealth of information specific to each individual, allowing them to design personalized, targeted therapies that directly address the unique characteristics of the patient's cancer.
The power of this groundbreaking approach lies in its ability to identify the treatments with the highest potential for each patient. By avoiding trial-and-error treatment plans, Onconomics Plus RGCC speeds up the path to effective cancer management. It directs patients and their healthcare teams toward the most promising therapeutic options, saving valuable time and resources.
​
Onconomics Plus RGCC provides information about the following details:
Circulating tumor cell (CTC) count,
-
Genetic and physiological expressions of your cancer cells,
-
Effectiveness of 50+ chemotherapeutic agents on your cancer cells,
-
Effectiveness of 50+ natural substances on your cancer cells.